Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2008 | 04-2008 | 01-2008 | 10-2007 | 07-2007 | |
| Sales | 28 | 18 | 22 | 0 | 0 |
| Gross Profit | 28 | 18 | 22 | N/A | N/A |
| Operating Expenses | 1,263 | 1,636 | 1,455 | 1,064 | 821 |
| Operating Income | -1,235 | -1,618 | -1,432 | -1,064 | -821 |
| Interest Expense | 2 | 2 | 2 | 133 | 109 |
| Other Income | 3 | 11 | 33 | 797 | 2,048 |
| Pre-tax Income | -1,234 | -1,609 | -1,402 | -400 | 1,118 |
| Net Income Continuous | -1,234 | -1,609 | -1,402 | -400 | 1,118 |
| Net Income | $-1,234 | $-1,609 | $-1,402 | $-400 | $1,118 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | N/A | 0.02 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | 0.00 | 0.02 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | N/A | 0.02 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | 0.00 | 0.02 |
| EBITDA(a) | $-1,208 | $-1,591 | $-1,408 | $-960 | $-784 |